Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)
Clinical trial NCT05508074 · COMPLETED
Trial details
- NCT number
- NCT05508074
- Sponsor
- InFlectis BioScience
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2024-11-14
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.